Previous Close | 343.40 |
Open | 350.60 |
Bid | 350.50 x 50000 |
Ask | 359.30 x 50000 |
Day's Range | 350.60 - 350.60 |
52 Week Range | 94.81 - 368.10 |
Volume | |
Avg. Volume | 3 |
Market Cap | 17.378B |
Beta (5Y Monthly) | 0.91 |
PE Ratio (TTM) | 26.24 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 3.15 (0.92%) |
Ex-Dividend Date | Feb 15, 2024 |
1y Target Est | N/A |
LSB (LXU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Danaher's (DHR) Q1 earnings are likely to be hurt by weakness in the Biotechnology unit. Improving supply chains and strong price realization are expected to be positives.
Recently, Zacks.com users have been paying close attention to Carlisle (CSL). This makes it worthwhile to examine what the stock has in store.